Skip to content
    Fund+ logo

    Fund+

    Leuven, BelgiumFounded 2015

    Fund+ is a Belgian venture capital firm based in Leuven that invests in innovative European Life Sciences companies, primarily in therapeutics, diagnostics, and medical devices. It is an open-ended fund for long-term equity investment with a focus on Belgium, targeting companies at Series A or B stage that have reached proof of concept.

    46% of their portfolio is in Biotech & Life Sciences. Deal activity decreased year-over-year (2 deals in the last 12 months vs 3 prior). Average disclosed round size is $27.4M (across 16 rounds with reported amounts).

    Find people at Fund+ on Goldilocks AI

    Portfolio

    38

    Fund Size

    —

    Top Stage

    Series A

    Last 12 Mo

    2

    Team

    Bart De Leeuw

    Bart De Leeuw

    Partner/CFO

    Caroline Goddeeris

    Caroline Goddeeris

    Venture Partner

    Halina Novak

    Halina Novak

    Associate Partner

    Diane De Wyngaert

    Diane De Wyngaert

    Administrative Assistant

    Looking for someone who isn't listed here?

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    52 investments
    CompanyRound
    Tubulis logoTubulisOct 2025Series C
    TTubulis GmbHOct 2025Series C
    Hirundo logoHirundoJun 2025 · $8MSeed
    Coave Therapeutics logoCoave TherapeuticsJan 2025 · $33MSeries A
    Coave Therapeutics logoCoave TherapeuticsJan 2025 · $32MSeries A
    MMindPeak GmbHSep 2024 · $15.3MSeries A
    SUMA Wealth logoSUMA WealthFeb 2024 · $2.2MSeed
    CConfo TherapeuticsJan 2024Series B
    Bonside logoBonsideJun 2023 · $4.3MSeed
    ECL logoECLJan 2023 · $7MSeries A
    eTheRNA Immunotherapies logoeTheRNA ImmunotherapiesAug 2022Unknown
    eTheRNA logoeTheRNAAug 2022Unknown
    Tubulis logoTubulisMay 2022Series B
    TTubulis GmbHMay 2022Series B
    SmartHop logoSmartHopApr 2022 · $30MSeries B
    TTargED Biopharmaceuticals B.V.Feb 2022Series A
    TTarged BiopharmaceuticalsJan 2022Series A
    TTubulis GmbHJan 2022Series B
    TTargED Biopharmaceuticals B.V.Jan 2022Series A
    Novadip Biosciences logoNovadip BiosciencesJan 2022Series B
    EYED PHARMA logoEYED PHARMADec 2021Unknown
    OnePipe logoOnePipeNov 2021 · $3.5MUnknown
    Podcastle logoPodcastleOct 2021 · $7MSeed
    Egle Therapeutics logoEgle TherapeuticsOct 2021Series A
    Cardior Pharmaceuticals GmbH logoCardior Pharmaceuticals GmbHAug 2021Series B
    Page 1 of 3

    Looking for the people behind these companies?

    Top Co-Investors

    Last updated: 18 November 2026